Filter
1506
Filtered Results: 1506
Text search:
drug
approval
Featured
Recommendations
105
New Publications
446
Language
Document type
No document type
913
Studies & Reports
253
Guidelines
186
Manuals
64
Strategic & Response Plan
35
Fact sheets
28
Training Material
15
Situation Updates
5
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
42
Nigeria
39
South Africa
37
Malawi
35
Ethiopia
32
Nepal
32
Sierra Leone
30
Western and Central Europe
29
Myanmar / Burma
26
Liberia
25
Ukraine
25
Ghana
24
Bangladesh
24
Zambia
23
Tanzania
22
Rwanda
19
Latin America and the Carribbean
19
Namibia
17
Lesotho
17
Africa
15
Zimbabwe
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Senegal
8
Philippines
8
Cambodia
8
Asia
8
Syria
6
Thailand
6
Tajikistan
6
Russia
6
USA
5
Pakistan
5
Mozambique
5
Benin
5
Cameroon
4
South Sudan
4
Germany
4
China
4
Indonesia
4
Peru
4
East and Southern Africa
4
Venezuela
4
Albania
4
Afghanistan
3
Eswatini/ Swaziland
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Georgia
3
Vietnam
3
Guinea
2
Somalia
2
Iraq
2
Central African Republic
2
Brazil
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Western Pacific Region
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Haiti
1
Lebanon
1
Turkey
1
Sudan
1
Argentina
1
Colombia
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
127
Public Health
52
Women & Child Health
41
Pharmacy & Technologies
36
Key Resources
26
Capacity Building
12
Toolboxes
HIV
179
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
42
Ebola
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
17
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Polio
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ...
Updated Guidelines
Objective: To review the effectiveness of antibiotic stewardship interventions in hospitals in low- and middle-income countries.
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha...
The Lancet Published Online September 13, 2016 http://dx.doi.org/10.1016/S0140-6736(16)31404-0
The authors conduct an integrated survey of Antimicrobial Resistant Organisms (AMR) in drinking water, wastewater and surface water in three settings in Bangladesh: rural households, rural poultry farms, and urban food markets. Results show that untreated water discharged from rural households, poul...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to political instability over the last 40 years, Peru has experienced major changes on its epidemiological and...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Analysis of microfilaria prevalence data from 430 communities
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
